Morillas Hilda N, Zariwala Maimoona, Knowles Michael R
CF/Pulmonary Research and Treatment Center, University of North Carolina, Chapel Hill, NC 27599-7248, USA.
Respiration. 2007;74(3):252-63. doi: 10.1159/000101783.
Primary ciliary dyskinesia (PCD) is a genetically heterogeneous disorder reflecting abnormalities in the structure and function of motile cilia and flagella, causing impairment of mucociliary clearance, left-right body asymmetry, and sperm motility. Clinical manifestations include respiratory distress in term neonates, recurrent otosinopulmonary infections, bronchiectasis, situs inversus and/or heterotaxy, and male infertility. Genetic discoveries are emerging from family-based linkage studies and from testing candidate genes. Mutations in 2 genes, DNAI1 and DNAH5, frequently cause PCD as an autosomal recessive disorder. A clinical genetic test has been recently established for DNAI1 and DNAH5, which involves sequencing 9 exons that harbor the most common mutations. This approach will identify at least one mutation in these 2 genes in approximately 25% of PCD patients. If biallelic mutations are identified, the test is diagnostic. If only one mutation is identified, the full gene may be sequenced to search for a trans-allelic mutation. As more disease-causing gene mutations are identified, broader genetic screening panels will further identify patients with PCD. Ongoing investigations are beginning to identify genetic mutations in novel clinical phenotypes for PCD, such as congenital heart disease and male infertility, and new associations are being established between 'ciliary' genetic mutations and clinical phenotypes.
原发性纤毛运动障碍(PCD)是一种基因异质性疾病,反映了运动性纤毛和鞭毛结构与功能的异常,导致黏液纤毛清除功能受损、左右身体不对称以及精子活力下降。临床表现包括足月儿呼吸窘迫、反复的耳肺感染、支气管扩张、内脏反位和/或内脏异位以及男性不育。基于家系的连锁研究和候选基因检测不断有新的基因发现。DNAI1和DNAH5这两个基因的突变常导致PCD呈常染色体隐性遗传疾病。最近已针对DNAI1和DNAH5建立了一项临床基因检测,该检测涉及对包含最常见突变的9个外显子进行测序。这种方法将在约25%的PCD患者中识别出这两个基因中的至少一个突变。如果鉴定出双等位基因突变,则该检测具有诊断意义。如果仅鉴定出一个突变,则可能对整个基因进行测序以寻找反式等位基因突变。随着更多致病基因突变被识别,更广泛的基因筛查面板将进一步识别出PCD患者。正在进行的研究开始在PCD的新临床表型(如先天性心脏病和男性不育)中识别基因突变,并且正在建立“纤毛”基因突变与临床表型之间的新关联。